The endoluminal suturing devices market is projected to witness robust growth by 2027 owing to the rising demand for surgical procedures across the globe. Moreover, technological developments in the devices are expected to further support market growth through the forecast period.

The COVID-19 pandemic overburdened the global healthcare infrastructure. Patients awaiting elective surgical procedures feared the risk of exposure to the novel coronavirus at hospitals, which caused them to postpone their procedures. Thus, to reduce the burden on healthcare systems and to limit the transmission of the virus, elective surgeries were either cancelled or postponed, which adversely affected market demand across the globe.

With successful immunization drives, patients are now undertaking elective surgical procedures, which has propelled product adoption significantly. Moreover, industry leaders have been developing innovative technologies to accommodate emerging consumer demands and improve their market standing, thereby boosting market expansion.

For instance, in June 2021, Ethicon, a Johnson & Johnson subsidiary and a leading company in flexible endoluminal robotics and soft tissue microwave ablation, announced that the new medical technologies guidelines issued by the National Institute for Health and Care Excellence (NICE) had recommended the use of its Plus Sutures, which offer antibacterial protection, in surgical procedures within the National Health Service (NHS).

Furthermore, increasing research efforts to advance product technology has also been favorable for business outlook worldwide. To cite an instance, a June 2020 study published in the journal Gastrointestinal Endoscopy discussed a novel endoluminal suturing device for soft flexible endoscope in natural orifice transluminal endoscopic surgery (NOTES).

The study successfully demonstrated the viability and safety of the device in NOTES, which is an innovative surgical procedure, although with limited clinical applications. Existing endoscopic suturing devices only support needle insertion and withdrawal and can damage normal tissue, sometimes even causing perforation. The novel device was found to meet the surgical requirements in terms of knot tying and suturing.

The endoluminal suturing devices market has been bifurcated based on application, end-user, and region. On the basis of application, the market has been divided into GI defects, bariatric surgery, GERD, and others. The endoluminal suturing devices market valuation from the gastroesophageal reflux diseases (GERD) sub-segment is estimated to exceed USD 19.4 million by 2027, expanding at a steady pace over 2021-2027.

In terms of end-user, the market has been segregated into ambulatory surgical centers, hospitals, and others. In 2020, the hospitals sub-segment garnered a revenue of over USD 33.3 million and is speculated to grow at a notable CAGR through the forecast timeframe.

On the regional spectrum, Latin America accounted for about 16.3% of the endoluminal suturing devices market in 2020 and is anticipated to expand at a robust pace to reach a sizable revenue by the end of 2027. The Middle East & Africa endoluminal suturing devices market is calculated to exhibit substantial growth at around 14.5% CAGR through the forecast period.